{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:45:00Z","timestamp":1794890700403,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82274016"],"award-info":[{"award-number":["No. 82274016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872934"],"award-info":[{"award-number":["81872934"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003746"],"award-info":[{"award-number":["82003746"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473910"],"award-info":[{"award-number":["82473910"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Leading Talent of Guangdong Special Support Program","award":["0720240120"],"award-info":[{"award-number":["0720240120"]}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2021A1515220031"],"award-info":[{"award-number":["2021A1515220031"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515011133"],"award-info":[{"award-number":["2023A1515011133"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2025A1515012395"],"award-info":[{"award-number":["2025A1515012395"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Program of Guangzhou","award":["No. 2023B03J1251"],"award-info":[{"award-number":["No. 2023B03J1251"]}]},{"name":"Key-Area Research and Development Program of Guangdong Province, China","award":["No. 2019B020229003"],"award-info":[{"award-number":["No. 2019B020229003"]}]},{"DOI":"10.13039\/501100012166","name":"National key research and development program","doi-asserted-by":"crossref","award":["No. 2017YFC0909301"],"award-info":[{"award-number":["No. 2017YFC0909301"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"DOI":"10.1186\/s11658-025-00759-x","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T10:04:29Z","timestamp":1752833069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["GPD2 inhibition impairs coagulation function via ROS\/NF-\u03baB\/P2Y12 pathway"],"prefix":"10.1186","volume":"30","author":[{"given":"Jiajie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoxia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6093-329X","authenticated-orcid":false,"given":"Weihua","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"issue":"10","key":"759_CR1","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","volume":"68","author":"GN Levine","year":"2016","unstructured":"Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, Mehran R, Mukherjee D, Newby LK, O\u2019Gara PT, Sabatine MS, Smith PK, Smith SC Jr. 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016;68(10):1082\u2013115. https:\/\/doi.org\/10.1016\/j.jacc.2016.03.513.","journal-title":"J Am Coll Cardiol"},{"key":"759_CR2","doi-asserted-by":"publisher","first-page":"m4760","DOI":"10.1136\/bmj.m4760","volume":"372","author":"SJ Corbett","year":"2021","unstructured":"Corbett SJ, Ftouh S, Lewis S, Lovibond K, Guideline Committee. Acute coronary syndromes: summary of updated NICE guidance. BMJ. 2021;372:m4760. https:\/\/doi.org\/10.1136\/bmj.m4760.","journal-title":"BMJ"},{"key":"759_CR3","doi-asserted-by":"publisher","unstructured":"Kamran H, Jneid H, Kayani WT, Virani SS, Levine GN, Nambi V, Khalid U. Oral antiplatelet therapy after acute coronary syndrome: a review. JAMA. 2021;325(15):1545-1555. https:\/\/doi.org\/10.1001\/jama.2021.0716. Erratum in: JAMA. 2021 Jul 13;326(2):190. https:\/\/doi.org\/10.1001\/jama.2021.9484.","DOI":"10.1001\/jama.2021.0716"},{"issue":"11","key":"759_CR4","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Freij A, Thors\u00e9n M, PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045\u201357. https:\/\/doi.org\/10.1056\/NEJMoa0904327.","journal-title":"N Engl J Med"},{"issue":"3","key":"759_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"M Valgimigli","year":"2018","unstructured":"Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, J\u00fcni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, ESC Scientific Document Group, ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39(3):213\u201360. https:\/\/doi.org\/10.1093\/eurheartj\/ehx419.","journal-title":"Eur Heart J"},{"key":"759_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fphar.2019.00209","volume":"10","author":"Q Zhu","year":"2019","unstructured":"Zhu Q, Zhong W, Wang X, Mai L, He G, Chen J, Tang L, Liu S, Lai W, Zhong S. Pharmacokinetic and pharmacogenetic factors contributing to platelet function recovery after single dose of ticagrelor in healthy subjects. Front Pharmacol. 2019;10:209. https:\/\/doi.org\/10.3389\/fphar.2019.00209.","journal-title":"Front Pharmacol"},{"issue":"25","key":"759_CR7","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","volume":"120","author":"PA Gurbel","year":"2009","unstructured":"Gurbel PA, Bliden KP, Butler K, Tantry US, Gesheff T, Wei C, Teng R, Antonino MJ, Patil SB, Karunakaran A, Kereiakes DJ, Parris C, Purdy D, Wilson V, Ledley GS, Storey RF. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study. Circulation. 2009;120(25):2577\u201385. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.912550.","journal-title":"Circulation"},{"issue":"9","key":"759_CR8","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1111\/j.1538-7836.2011.04419.x","volume":"9","author":"RF Storey","year":"2011","unstructured":"Storey RF, Bliden KP, Ecob R, Karunakaran A, Butler K, Wei C, Tantry U, Gurbel PA. Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responses. J Thromb Haemost. 2011;9(9):1730\u20137. https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04419.x.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"759_CR9","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1161\/CIRCRESAHA.121.318836","volume":"130","author":"LJ Corbin","year":"2022","unstructured":"Corbin LJ, White SJ, Taylor AE, Williams CM, Taylor K, van den Bosch MT, Teasdale JE, Jones M, Bond M, Harper MT, Falk L, Groom A, Hazell GGJ, Paternoster L, Munaf\u00f2 MR, Nordestgaard BG, Tybj\u00e6rg-Hansen A, Bojesen SE, Relton C, Min JL, Davey Smith G, Mumford AD, Poole AW, Timpson NJ. Epigenetic regulation of F2RL3 associates with myocardial infarction and platelet function. Circ Res. 2022;130(3):384\u2013400. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318836.","journal-title":"Circ Res"},{"key":"759_CR10","doi-asserted-by":"publisher","first-page":"34570","DOI":"10.1038\/srep34570","volume":"6","author":"XG Li","year":"2016","unstructured":"Li XG, Ma N, Wang B, Li XQ, Mei SH, Zhao K, Wang YJ, Li W, Zhao ZG, Sun SS, Miao ZR. The impact of P2Y12 promoter DNA methylation on the recurrence of ischemic events in Chinese patients with ischemic cerebrovascular disease. Sci Rep. 2016;6:34570. https:\/\/doi.org\/10.1038\/srep34570.","journal-title":"Sci Rep"},{"key":"759_CR11","doi-asserted-by":"publisher","first-page":"450814","DOI":"10.1155\/2014\/450814","volume":"2014","author":"J Su","year":"2014","unstructured":"Su J, Li X, Yu Q, Liu Y, Wang Y, Song H, Cui H, Du W, Fei X, Liu J, Lin S, Wang J, Zheng W, Zhong J, Zhang L, Tong M, Xu J, Chen X. Association of P2Y12 gene promoter DNA methylation with the risk of clopidogrel resistance in coronary artery disease patients. Biomed Res Int. 2014;2014:450814. https:\/\/doi.org\/10.1155\/2014\/450814.","journal-title":"Biomed Res Int"},{"issue":"2","key":"759_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1691\/ph.2015.4756","volume":"70","author":"J Yang","year":"2015","unstructured":"Yang J, Zhou JS, Zhao YX, Yang ZH, Zhao HD, Zhang YD, Zou JJ. ABCB1 hypomethylation is associated with decreased antiplatelet effects of clopidogrel in Chinese ischemic stroke patients. Pharmazie. 2015;70(2):97\u2013102. https:\/\/doi.org\/10.1691\/ph.2015.4756.","journal-title":"Pharmazie"},{"issue":"10","key":"759_CR13","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00228-017-2298-z","volume":"73","author":"X Li","year":"2017","unstructured":"Li X, Zhao K, Ma N, Sun S, Miao Z, Zhao Z. Association of ABCB1 promoter methylation with aspirin exposure, platelet function, and clinical outcomes in Chinese intracranial artery stenosis patients. Eur J Clin Pharmacol. 2017;73(10):1261\u20139. https:\/\/doi.org\/10.1007\/s00228-017-2298-z.","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"759_CR14","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s40262-017-0595-4","volume":"57","author":"HP Lei","year":"2018","unstructured":"Lei HP, Yu XY, Wu H, Kang YH, Zhong WP, Cai LY, Zhang MZ, Chen JY, Mai LP, Ding QS, Yang M, Zhong SL. Effects of PON1 gene promoter DNA methylation and genetic variations on the clinical outcomes of dual antiplatelet therapy for patients undergoing percutaneous coronary intervention. Clin Pharmacokinet. 2018;57(7):817\u201329. https:\/\/doi.org\/10.1007\/s40262-017-0595-4.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"759_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrg.2017.80","volume":"19","author":"F Lyko","year":"2018","unstructured":"Lyko F. The DNA methyltransferase family: a versatile toolkit for epigenetic regulation. Nat Rev Genet. 2018;19(2):81\u201392. https:\/\/doi.org\/10.1038\/nrg.2017.80.","journal-title":"Nat Rev Genet"},{"issue":"7472","key":"759_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nature12750","volume":"502","author":"RM Kohli","year":"2013","unstructured":"Kohli RM, Zhang Y. TET enzymes, TDG and the dynamics of DNA demethylation. Nature. 2013;502(7472):472\u20139. https:\/\/doi.org\/10.1038\/nature12750.","journal-title":"Nature"},{"issue":"1","key":"759_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cell.2016.08.056","volume":"167","author":"XS Liu","year":"2016","unstructured":"Liu XS, Wu H, Ji X, Stelzer Y, Wu X, Czauderna S, Shu J, Dadon D, Young RA, Jaenisch R. Editing DNA methylation in the mammalian genome. Cell. 2016;167(1):233-247.e17. https:\/\/doi.org\/10.1016\/j.cell.2016.08.056.","journal-title":"Cell"},{"issue":"3","key":"759_CR18","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.bbabio.2012.11.014","volume":"1827","author":"T Mr\u00e1\u010dek","year":"2013","unstructured":"Mr\u00e1\u010dek T, Drahota Z, Hou\u0161t\u011bk J. The function and the role of the mitochondrial glycerol-3-phosphate dehydrogenase in mammalian tissues. Biochim Biophys Acta. 2013;1827(3):401\u201310. https:\/\/doi.org\/10.1016\/j.bbabio.2012.11.014.","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"759_CR19","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1111\/jth.14274","volume":"16","author":"M Aibibula","year":"2018","unstructured":"Aibibula M, Naseem KM, Sturmey RG. Glucose metabolism and metabolic flexibility in blood platelets. J Thromb Haemost. 2018;16(11):2300\u201314. https:\/\/doi.org\/10.1111\/jth.14274.","journal-title":"J Thromb Haemost"},{"issue":"9","key":"759_CR20","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1161\/CIRCULATIONAHA.116.026995","volume":"136","author":"L Hu","year":"2017","unstructured":"Hu L, Chang L, Zhang Y, Zhai L, Zhang S, Qi Z, Yan H, Yan Y, Luo X, Zhang S, Wang Y, Kunapuli SP, Ye H, Ding Z. Platelets express activated P2Y12 receptor in patients with diabetes mellitus. Circulation. 2017;136(9):817\u201333. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.026995.","journal-title":"Circulation"},{"issue":"9","key":"759_CR21","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s41590-019-0517-8","volume":"20","author":"PK Langston","year":"2019","unstructured":"Langston PK, Nambu A, Jung J, Shibata M, Aksoylar HI, Lei J, Xu P, Doan MT, Jiang H, MacArthur MR, Gao X, Kong Y, Chouchani ET, Locasale JW, Snyder NW, Horng T. Glycerol phosphate shuttle enzyme GPD2 regulates macrophage inflammatory responses. Nat Immunol. 2019;20(9):1186\u201395. https:\/\/doi.org\/10.1038\/s41590-019-0517-8.","journal-title":"Nat Immunol"},{"issue":"25","key":"759_CR22","doi-asserted-by":"publisher","first-page":"9869","DOI":"10.1074\/jbc.AAC119.008929","volume":"293","author":"EL Robb","year":"2018","unstructured":"Robb EL, Hall AR, Prime TA, Eaton S, Szibor M, Viscomi C, James AM, Murphy MP. Control of mitochondrial superoxide production by reverse electron transport at complex I. J Biol Chem. 2018;293(25):9869\u201379. https:\/\/doi.org\/10.1074\/jbc.AAC119.008929.","journal-title":"J Biol Chem"},{"issue":"7527","key":"759_CR23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature13909","volume":"515","author":"ET Chouchani","year":"2014","unstructured":"Chouchani ET, Pell VR, Gaude E, Aksentijevi\u0107 D, Sundier SY, Robb EL, Logan A, Nadtochiy SM, Ord ENJ, Smith AC, Eyassu F, Shirley R, Hu CH, Dare AJ, James AM, Rogatti S, Hartley RC, Eaton S, Costa ASH, Brookes PS, Davidson SM, Duchen MR, Saeb-Parsy K, Shattock MJ, Robinson AJ, Work LM, Frezza C, Krieg T, Murphy MP. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515(7527):431\u20135. https:\/\/doi.org\/10.1038\/nature13909.","journal-title":"Nature"},{"issue":"3","key":"759_CR24","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"DB Zorov","year":"2014","unstructured":"Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 2014;94(3):909\u201350. https:\/\/doi.org\/10.1152\/physrev.00026.2013.","journal-title":"Physiol Rev"},{"issue":"3","key":"759_CR25","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","volume":"132","author":"MS Hayden","year":"2008","unstructured":"Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell. 2008;132(3):344\u201362. https:\/\/doi.org\/10.1016\/j.cell.2008.01.020.","journal-title":"Cell"},{"issue":"7","key":"759_CR26","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1182\/blood-2010-08-263111","volume":"117","author":"M Cattaneo","year":"2011","unstructured":"Cattaneo M. The platelet P2Y\u2081\u2082 receptor for adenosine diphosphate: congenital and drug-induced defects. Blood. 2011;117(7):2102\u201312. https:\/\/doi.org\/10.1182\/blood-2010-08-263111.","journal-title":"Blood"},{"issue":"12","key":"759_CR27","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1161\/ATVBAHA.110.213702","volume":"30","author":"BH Rauch","year":"2010","unstructured":"Rauch BH, Rosenkranz AC, Ermler S, B\u00f6hm A, Driessen J, Fischer JW, Sugidachi A, Jakubowski JA, Schr\u00f6r K. Regulation of functionally active P2Y12 ADP receptors by thrombin in human smooth muscle cells and the presence of P2Y12 in carotid artery lesions. Arterioscler Thromb Vasc Biol. 2010;30(12):2434\u201342. https:\/\/doi.org\/10.1161\/ATVBAHA.110.213702.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"759_CR28","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1182\/blood.2020006115","volume":"137","author":"K Kammers","year":"2021","unstructured":"Kammers K, Taub MA, Rodriguez B, Yanek LR, Ruczinski I, Martin J, Kanchan K, Battle A, Cheng L, Wang ZZ, Johnson AD, Leek JT, Faraday N, Becker LC, Mathias RA. Transcriptional profile of platelets and iPSC-derived megakaryocytes from whole-genome and RNA sequencing. Blood. 2021;137(7):959\u201368. https:\/\/doi.org\/10.1182\/blood.2020006115.","journal-title":"Blood"},{"issue":"2","key":"759_CR29","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/ijms23020776","volume":"23","author":"Y Heo","year":"2022","unstructured":"Heo Y, Jeon H, Namkung W. PAR4-mediated PI3K\/Akt and RhoA\/ROCK signaling pathways are essential for thrombin-induced morphological changes in MEG-01 cells. Int J Mol Sci. 2022;23(2):776. https:\/\/doi.org\/10.3390\/ijms23020776.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"759_CR30","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1046\/j.1365-2141.1998.00576.x","volume":"100","author":"K Takeuchi","year":"1998","unstructured":"Takeuchi K, Satoh M, Kuno H, Yoshida T, Kondo H, Takeuchi M. Platelet-like particle formation in the human megakaryoblastic leukaemia cell lines, MEG-01 and MEG-01s. Br J Haematol. 1998;100(2):436\u201344. https:\/\/doi.org\/10.1046\/j.1365-2141.1998.00576.x.","journal-title":"Br J Haematol"},{"issue":"4","key":"759_CR31","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.bbrc.2005.06.017","volume":"333","author":"SK Chowdhury","year":"2005","unstructured":"Chowdhury SK, Gemin A, Singh G. High activity of mitochondrial glycerophosphate dehydrogenase and glycerophosphate-dependent ROS production in prostate cancer cell lines. Biochem Biophys Res Commun. 2005;333(4):1139\u201345. https:\/\/doi.org\/10.1016\/j.bbrc.2005.06.017.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"759_CR32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1001\/jamacardio.2024.0133","volume":"9","author":"M Valgimigli","year":"2024","unstructured":"Valgimigli M, Gragnano F, Branca M, Franzone A, da Costa BR, Baber U, Kimura T, Jang Y, Hahn JY, Zhao Q, Windecker S, Gibson CM, Watanabe H, Kim BK, Song YB, Zhu Y, Vranckx P, Mehta S, Ando K, Hong SJ, Gwon HC, Serruys PW, Dangas GD, McFadden EP, Angiolillo DJ, Heg D, Calabr\u00f2 P, J\u00fcni P, Mehran R, Single Versus Dual Antiplatelet Therapy (Sidney-3) Collaboration. Ticagrelor or clopidogrel monotherapy vs dual antiplatelet therapy after percutaneous coronary intervention: a systematic review and patient-level meta-analysis. JAMA Cardiol. 2024;9(5):437\u201348. https:\/\/doi.org\/10.1001\/jamacardio.2024.0133.","journal-title":"JAMA Cardiol."},{"issue":"3","key":"759_CR33","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1365-2141.2004.05032.x","volume":"126","author":"P Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 P. P-selectin in haemostasis. Br J Haematol. 2004;126(3):298\u2013306. https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05032.x.","journal-title":"Br J Haematol"},{"issue":"17","key":"759_CR34","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1182\/bloodadvances.2018019166","volume":"2","author":"S Joshi","year":"2018","unstructured":"Joshi S, Banerjee M, Zhang J, Kesaraju A, Pokrovskaya ID, Storrie B, Whiteheart SW. Alterations in platelet secretion differentially affect thrombosis and hemostasis. Blood Adv. 2018;2(17):2187\u201398. https:\/\/doi.org\/10.1182\/bloodadvances.2018019166.","journal-title":"Blood Adv"},{"issue":"1","key":"759_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12964-016-0144-z","volume":"14","author":"PM Benz","year":"2016","unstructured":"Benz PM, Laban H, Zink J, G\u00fcnther L, Walter U, Gambaryan S, Dib K. Vasodilator-Stimulated Phosphoprotein (VASP)-dependent and -independent pathways regulate thrombin-induced activation of Rap1b in platelets. Cell Commun Signal. 2016;14(1):21. https:\/\/doi.org\/10.1186\/s12964-016-0144-z.","journal-title":"Cell Commun Signal"},{"issue":"2","key":"759_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1182\/blood.2021011010","volume":"139","author":"JA Willson","year":"2022","unstructured":"Willson JA, Arienti S, Sadiku P, Reyes L, Coelho P, Morrison T, Rinaldi G, Dockrell DH, Whyte MKB, Walmsley SR. Neutrophil HIF-1\u03b1 stabilization is augmented by mitochondrial ROS produced via the glycerol 3-phosphate shuttle. Blood. 2022;139(2):281\u20136. https:\/\/doi.org\/10.1182\/blood.2021011010.","journal-title":"Blood"},{"issue":"5","key":"759_CR37","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.celrep.2012.10.009","volume":"2","author":"MM Kami\u0144ski","year":"2012","unstructured":"Kami\u0144ski MM, Sauer SW, Kami\u0144ski M, Opp S, Ruppert T, Grigaravi\u010dius P, Grudnik P, Gr\u00f6ne HJ, Krammer PH, G\u00fclow K. T cell activation is driven by an ADP-dependent glucokinase linking enhanced glycolysis with mitochondrial reactive oxygen species generation. Cell Rep. 2012;2(5):1300\u201315. https:\/\/doi.org\/10.1016\/j.celrep.2012.10.009.","journal-title":"Cell Rep"},{"issue":"2","key":"759_CR38","doi-asserted-by":"publisher","first-page":"438","DOI":"10.7150\/thno.75973","volume":"13","author":"S Oh","year":"2023","unstructured":"Oh S, Jo S, Bajzikova M, Kim HS, Dao TTP, Rohlena J, Kim JM, Neuzil J, Park S. Non-bioenergetic roles of mitochondrial GPD2 promote tumor progression. Theranostics. 2023;13(2):438\u201357. https:\/\/doi.org\/10.7150\/thno.75973.","journal-title":"Theranostics"},{"issue":"2","key":"759_CR39","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/ph7020192","volume":"7","author":"G Singh","year":"2014","unstructured":"Singh G. Mitochondrial FAD-linked Glycerol-3-phosphate dehydrogenase: a target for cancer therapeutics. Pharmaceuticals (Basel). 2014;7(2):192\u2013206. https:\/\/doi.org\/10.3390\/ph7020192.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"759_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1161\/CIRCRESAHA.123.322914","volume":"134","author":"S Jacob","year":"2024","unstructured":"Jacob S, Kosaka Y, Bhatlekar S, Denorme F, Benzon H, Moody A, Moody V, Tugolukova EA, Hull G, Kishimoto N, Manne BK, Guo L, Souvenir R, Seliger BJ, Eustes AS, Hoerger K, Tolley ND, Fatahian AN, Boudina S, Christiani DC, Wei Y, Ju C, Campbell RA, Rondina MT, Abel ED, Bray PF, Weyrich AS, Rowley JW. Mitofusin-2 regulates platelet mitochondria and function. Circ Res. 2024;134(2):143\u201361. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.322914.","journal-title":"Circ Res"},{"issue":"14","key":"759_CR41","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1182\/blood.2020010331","volume":"138","author":"H \u00d8stergaard","year":"2021","unstructured":"\u00d8stergaard H, Lund J, Greisen PJ, Kjellev S, Henriksen A, Lorenzen N, Johansson E, R\u00f8der G, Rasch MG, Johnsen LB, Egebjerg T, Lund S, Rahbek-Nielsen H, Gandhi PS, Lamberth K, Loftager M, Andersen LM, Bonde AC, Stavenuiter F, Madsen DE, Li X, Holm TL, Ley CD, Thygesen P, Zhu H, Zhou R, Thorn K, Yang Z, Hermit MB, Bjelke JR, Hansen BG, Hilden I. A factor VIIIa-mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice. Blood. 2021;138(14):1258\u201368. https:\/\/doi.org\/10.1182\/blood.2020010331.","journal-title":"Blood"},{"issue":"5","key":"759_CR42","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.hoc.2016.06.002","volume":"30","author":"RI Handin","year":"2016","unstructured":"Handin RI. The history of antithrombotic therapy: the discovery of heparin, the vitamin K antagonists, and the utility of aspirin. Hematol Oncol Clin North Am. 2016;30(5):987\u201393. https:\/\/doi.org\/10.1016\/j.hoc.2016.06.002.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"7","key":"759_CR43","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1080\/17474086.2017.1345306","volume":"10","author":"I Baluwala","year":"2017","unstructured":"Baluwala I, Favaloro EJ, Pasalic L. Therapeutic monitoring of unfractionated heparin - trials and tribulations. Expert Rev Hematol. 2017;10(7):595\u2013605. https:\/\/doi.org\/10.1080\/17474086.2017.1345306.","journal-title":"Expert Rev Hematol"},{"issue":"11","key":"759_CR44","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1097\/PCC.0000000000002104","volume":"20","author":"JS Penk","year":"2019","unstructured":"Penk JS, Reddy S, Polito A, Cisco MJ, Allan CK, Bembea M, Giglia TM, Cheng HH, Thiagarajan RR, Dalton HJ. Bleeding and thrombosis with pediatric extracorporeal life support: a roadmap for management, research, and the future from the pediatric cardiac intensive care society: part 2. Pediatr Crit Care Med. 2019;20(11):1034\u20139. https:\/\/doi.org\/10.1097\/PCC.0000000000002104.","journal-title":"Pediatr Crit Care Med"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00759-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-025-00759-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00759-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T10:04:31Z","timestamp":1752833071000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmbl.biomedcentral.com\/articles\/10.1186\/s11658-025-00759-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["759"],"URL":"https:\/\/doi.org\/10.1186\/s11658-025-00759-x","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Review Committee of Guangdong Provincial People\u2019s Hospital approved our human and animal studies (no. GDREC:KY2023-090-02) on 10 March 2023, in compliance with the \u201cEthical Review Measures for Biomedical Research Involving Human Subjects\u201d and \u201cGuidance on the Humane Treatment of Laboratory Animals\u201d issued by the Ministry of Science and Technology of China, as well as relevant international animal welfare guidelines and regulations (including the ICLAS statement). Our research strictly adhered to the Declaration of Helsinki and other applicable guidelines. The study was registered with ClinicalTrials.gov (NCT03092076) and was strictly conducted in accordance with the relevant provisions of the Declaration of Helsinki and received approval from the Medical Research Ethics Committee of Guangdong Provincial People\u2019s Hospital (no. GDREC2015143H(R1) and no. GDREC2017071H). Each patient was fully informed of the details of the research and the entire process. Furthermore, written informed consent was obtained from all participants (no. 20150115 and no.20170211).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}